Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
1997-4-4
|
pubmed:abstractText |
Silicone breast implants have been surgical routine for over 30 years. An association between silicone augmentation and immune related diseases has been reported in approximately 100 cases. In a retrospective single center study we investigated 36 non-selected women with silicone breast implants and 36 sex- and age-matched controls. Autoimmune reactions were evaluated by measuring antinuclear antibodies (ANA), rheumatoid factor (RF) and thyroid gland antibodies (TMS), along with angiotensin-converting enzyme (ACE), C-reactive protein (CRP) and other immunological and laboratory parameters. In the controls only 3 (8%) women had an elevated ANA titer and 1 demonstrated thyroid autoantibodies (microsomal), giving a total of 4 (11%) women with detectable autoantibodies. By contrast, 12 (33%) of the 36 women with silicone augmentation had raised ANA titers (> or = 1 : 80), a significantly higher percentage than in the control group (p < 0.02). Of the 12 women, 1 showed antismooth muscle antibodies (ASMA; titer 1 : 40) and 2 of the patients displayed antineutrophilic cytoplasm antibodies (ANCA; 1 : 320 and 1 : 40, respectively), one of the latter also being positive for rheumatoid factor. 2 further women demonstrated thyroid autoantibodies (microsomal), giving a total of 14 (39%) women in whom significant autoantibodies were detectable. Clinical symptoms (musculoskeletal) were present in 1 patient. Most of the observed autoantibodies were organ-unspecific, with a predominance of elevated ANA titers of the heterogeneous type and not related to a distinct clinical entity. However, none of the investigated women with silicone breast implants showed clinical symptoms or signs of connective tissue disease according to ARA criteria.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0043-5325
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
781-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9017890-Acute-Phase Proteins,
pubmed-meshheading:9017890-Adult,
pubmed-meshheading:9017890-Aged,
pubmed-meshheading:9017890-Aged, 80 and over,
pubmed-meshheading:9017890-Austria,
pubmed-meshheading:9017890-Autoantibodies,
pubmed-meshheading:9017890-Autoimmune Diseases,
pubmed-meshheading:9017890-Breast Implants,
pubmed-meshheading:9017890-Female,
pubmed-meshheading:9017890-Humans,
pubmed-meshheading:9017890-Mammaplasty,
pubmed-meshheading:9017890-Middle Aged,
pubmed-meshheading:9017890-Organ Specificity,
pubmed-meshheading:9017890-Retrospective Studies,
pubmed-meshheading:9017890-Risk Factors,
pubmed-meshheading:9017890-Silicones
|
pubmed:year |
1996
|
pubmed:articleTitle |
Autoimmune reactions in patients with silicone breast implants.
|
pubmed:affiliation |
II. Department of Medicine, General Hospital Linz.
|
pubmed:publicationType |
Journal Article
|